Xconomy National

Archives

by in

Entry	Author	Date	Location
Myriant Gets $60M, BioVex Bought By Amgen, Raindance Wraps Up $37.5M, & More Boston-Area Deals News	Erin Kutz	01/26/11	Boston
ArQule Raising $41M in Stock Sale	Ryan McBride	01/21/11	Boston
Lycera Keeps Its Investors Happy, Snags $11M to Pursue New Autoimmune Drugs	Luke Timmerman	04/28/10	Detroit
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten	Luke Timmerman	10/08/09	Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter	Luke Timmerman	03/17/09	Boston
Broad Institute Scientists’ Forma Therapeutics Raises $25M, Aims to Knock Out Underpinnings of Cancer	Ryan McBride	01/06/09	Boston
New RNAi Drugs, Major Cutbacks at Targanta, Big Partnerships for Arqule and Archemix, & More Boston-Area Life Sciences News	Wade Roush	12/24/08	Boston
Outsourced Chemistry Shop, BioBlocks, Sees Growth in San Diego and Hungary	Luke Timmerman	12/23/08	San Diego
ArQule Snags $60M From Daiichi Sankyo	Luke Timmerman	12/19/08	Boston
Another Next-Generation RNAi Startup Emerges, Makes Big Claims About Its Ability to Silence Bad Genes	Ryan McBride	12/18/08	Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter	Luke Timmerman	11/25/08	Boston
A Lawsuit for Biogen, A Suitor for Millennium, The Suits Who Made Their Own Fate, & More Life Sciences News	Rebecca Zacks	04/16/08	Boston
ArQule Gets a New CEO	Wade Roush	04/15/08	Boston
ArQule CEO Hill to Leave Post, Remains Mum on Next Step as Firm Hunts for Replacement	Malorye Allison	01/08/08	Boston
Page 1 of 1